The critical role of the PI3K/AKT/mTOR (PAM) pathway in cell survival, proliferation, growth, and apoptosis influences make it a promising drug target in the war against cancer (Sanchez et al., 2019; Khan et al., 2019). The gene discussed is AKT1; the disease is cancer.